Search
Search Results
-
The new framework of innovation biosphere for analysing innovation policies facing COVID-19 grand challenge
BackgroundFacing global grand challenges such as coronavirus disease 2019 (COVID-19) require the participation of various actors in different sectors...
-
Application of the Stanford Biodesign Framework in Healthcare Innovation Training and Commercialization of Market Appropriate Products: A Sco** Review
The Stanford Biodesign needs-centric framework can guide healthcare innovators to successfully adopt the ‘Identify, Invent and Implement’ framework...
-
Analysing the performance of a health innovation ecosystem in the COVID-19 crisis: complexity and chaos theory perspective
BackgroundThis research delves into the complexity management of collaborative networks and interorganizational systems in the health innovation...
-
The advancement of artificial intelligence in biomedical research and health innovation: challenges and opportunities in emerging economies
The advancement of artificial intelligence (AI), algorithm optimization and high-throughput experiments has enabled scientists to accelerate the...
-
Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models
BackgroundUnequal and inequitable access to Covid-19 vaccines in low- and middle-income countries (L&MICs) was a major political, ethical and public...
-
A comparative analysis of non-invasive prenatal testing in Ontario and Quebec: the role of governing style in health technology innovation & adoption
BackgroundWhile processes of adoption and the impacts of various health technologies have been extensively studied by health services and policy...
-
An intriguing vision for transatlantic collaborative health data use and artificial intelligence development
Our traditional approach to diagnosis, prognosis, and treatment, can no longer process and transform the enormous volume of information into...
-
Biodesign program introduction in Japan: promotion of entrepreneurship and viewpoints of education on medical technology innovation
The Stanford Biodesign program was first introduced in Japan in 2015 at three national universities to develop medical technology innovation and its...
-
New indicators and indexes for benchmarking university–industry–government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project
BackgroundWhile the European Union is striving to become the ‘Innovation Union’, there remains a lack of quantifiable indicators to compare and...
-
Improvement studies for equitable and evidence-based innovation: an overview of the ‘IM-SEEN’ model
BackgroundHealth inequalities are ubiquitous, and as countries seek to expand service coverage, they are at risk of exacerbating existing...
-
Using provocative design to foster electronic informed consent innovation
BackgroundThe development of technological applications in clinical research, such as electronic informed consent (eIC), is on the rise. The...
-
The portrayal of electronic cigarettes in Indonesia: a content analysis of news media
BackgroundThe news media play an essential role in sha** public opinion. Analyzing a specific issue reported in the news media provides insight and...
-
Why is repositioning public health innovation towards a social paradigm necessary? A reflection on the field of public health through the examples of Ebola and Covid-19
Health innovations are generally oriented on a techno-economic vision. In this perspective, technologies are seen as an end in themselves, and there...
-
Efficacy of human resource development program for young industry personnel who will be involved in future medical device development
BackgroundTraining next-generation personnel from small/medium enterprises (SMEs) is an urgent issue in promoting medical device research and...
-
Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a sco** review and regulatory implications
BackgroundThe National Medical Products Administration (NMPA) in China has set to advance the regulatory capacity of traditional Chinese medicines...
-
The global patent landscape of emerging infectious disease monkeypox
BackgroundMonkeypox is an emerging infectious disease with confirmed cases and deaths in several parts of the world. In light of this crisis, this...
-
Focused ultrasound in neuro-oncology: the role of the Focused Ultrasound Foundation in driving adoption and innovation
The Focused Ultrasound Foundation was created to improve the lives of millions of people worldwide by accelerating the development of this...
-
Financing Drug Innovation in the US: Current Framework and Emerging Challenges
The current US drug innovation financing framework rests on the notion that a defined period of marketing exclusivity combined with the expectation...
-
Introducing Open Science in Teaching Health Economic Modelling
Open Science is gaining ground in all research fields, including health economics and outcomes research (HEOR). However, teaching Open Science is...
